Hepatology - European Medical Journal

Continue

Hepatology

Filter
EMJ
4 Mins
4th February 2015

AbbVie’s VIEKIRAX® (Ombitasvir/Paritaprevir/Ritonavir) and EXVIERA ® (Dasabuvir) Licensed for Use in the UK for the Treatment of Chronic Hepatitis C

MAIDENHEAD, UK, Jan. 19, 2015 – AbbVie’s all-oral, short course (12 weeks for the majority of patients), interferon-free treatments VIEKIRAX®…
EMJ
1 Mins
12th January 2015

Artificial Liver Leads the Way as New Life-Saver

BIOARTIFICIAL livers could possess the ability to sustain liver failure (LF) patients until their own internal organs can repair themselves or…
EMJ
1 Mins
6th January 2015

Liver Cancer Menace May Lie in Surrounding Immunity

MACROPHAGES may constitute the next target for liver cancer treatment as the presence of epidermal growth factor receptor (EGFR) in the cells…
EMJ
1 Mins
6th January 2015

Gene Culprit behind Metabolic Syndrome Revealed

HEALTHY gut microbiota may be the key to tackling metabolic syndrome (MetS); when a particular gene, known as Toll-like receptor 5 (TLR5), is…
EMJ
2 Mins
25th November 2014

Experts Call for Greater Awareness of Alcohol Related Liver Disease and Liver Cancer

Vienna, 24 November 2014 – United European Gastroenterology (UEG) is supporting the second annual Awareness Week on Alcohol Related Harm (AWARH)